Search results
Thermo Fisher (TMO) Unveils CorEvitas Pharmacovigilance Platform
Zacks via Yahoo Finance· 6 months agoThermo Fisher Scientific TMO recently announced the launch of CorEvidence, its proprietary...
Novavax (NVAX) Reports Positive Data on COVID/FLU Combo Jab Study
Zacks via Yahoo Finance· 2 years agoNovavax NVAX announced positive top-line results from a phase I/II study evaluating the safety and...
Biotech Stock Roundup: GSK's Drug Approval, MRNA's Vaccine News, PTCT & SPRY Down
Zacks via Yahoo Finance· 9 months agoIt was a busy week for the biotech sector, with a lot of important regulatory and pipeline updates....
AMO Pharma to conduct Phase III trial of DM1 treatment
Clinical Trials Arena via Yahoo Finance· 1 month agoAMO Pharma has announced its plans to initiate a Phase III clinical trial for its investigational...
Nabriva (NBRV) Posts Positive Data From Cystic Fibrosis Study
Zacks via Yahoo Finance· 2 years agoNabriva (NBRV) posts positive top-line data from the phase I study evaluating oral and intravenous...
VA plans research on using psychedelics to treat PTSD, depression
Military Times via Yahoo News· 5 months agoVeterans Affairs leaders plan to launch new studies on the use of psychedelic compounds to treat...
Fact check: Post falsely claims that FDA said Pfizer vaccines cause blood clots
USA TODAY via Yahoo News· 1 year agoThe claim: The FDA said Pfizer vaccines cause blood clotting The Food and Drug Administration...
House committee to vote on changing rules for prior authorization, insulin price caps
Springfield News-Leader via Yahoo News· 5 months agoWhile the Missouri Senate devolved into infighting at the end of last week — culminating in an...
Biophytis Shares Gain After Detailed Data From Pivotal COVID-19 Treatment Study
Benzinga via Yahoo Finance· 2 years agoBiophytis SA (NASDAQ: BPTS) has released the full results from its phase 2-3 COVA study evaluating...
Praxis Precision Outlines Upcoming Plans For Pediatric Epilepsy Programs
Benzinga via Yahoo Finance· 2 years agoPraxis Precision Medicines Inc (NASDAQ: PRAX) plans to start the PRAX-222 EMBRAVE study for...